Abiomed Inc (ABMD) 115.93 $ABMD Becton, Dickinson (BDX)

New Post Public Reply Private Reply Replies (0) Message Board

Jul 11, 2016 at 11:01 AM

Abiomed Inc (ABMD) 115.93 $ABMD

Becton, Dickinson (BDX) at 52-Week High on New Launches
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 7:59AM CDT
Shares of Becton, Dickinson and Company (BDX) scaled a new 52-week high of $173.24 on Jul 7.
HYH: 34.17 (-0.30), DSCI: 4.33 (+0.11), ABMD: 115.93 (+1.78), BDX: 176.65 (+1.01)

Luminex (LMNX) Rallies on FDA Nod for Aries M1 System
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 5:25PM CDT
Luminex Corp. (LMNX) recently announced FDA approval for the Aries M1 system.
ABMD: 115.93 (+1.78), CHEK: 1.35 (-0.09), LMNX: 21.57 (-0.09), MLAB: 126.76 (+0.96)

The Ensign Group (ENSG) Acquires Riverbend, Shares Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 3:52PM CDT
The Ensign Group Inc. (ENSG) recently acquired Kansas City-based Riverbend Post Acute Rehabilitation.
ENSG: 21.80 (+0.43), ABMD: 115.93 (+1.78), ABCO: 37.75 (+0.33), BEAT: 17.24 (+0.70)

TrovaGene Inks Partnership with University of Michigan
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 3:31PM CDT
TrovaGene Inc. (TROV) is collaborating with the University of Michigan to conduct a multi-phased research program using Trovera KRAS ctDNA liquid biopsy test.
ABMD: 115.93 (+1.78), MASI: 52.23 (-0.10), TROV: 4.95 (-0.16), MLAB: 126.76 (+0.96)

Look for Shares of ABIOMED to Potentially Pullback after Yesterday's 1.27% Rise
Comtex SmarTrend(R) - Thu Jul 07, 3:25PM CDT
ABIOMED (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $111.14 to a high of $113.64. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $111.55 on volume of 187,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABMD: 115.93 (+1.78)

Uptrend Call Working As ABIOMED Stock Rises 32.2% (ABMD)
Comtex SmarTrend(R) - Thu Jul 07, 12:26AM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 4 months, ABIOMED has returned 32.19% as of today's recent price of $111.44.
ABMD: 115.93 (+1.78)

Technical Coverage on Medical Appliances & Equipment Stocks - Edwards Lifesciences, Stryker, Accuray, and ABIOMED
PR Newswire - Tue Jul 05, 7:00AM CDT
On Friday, July 01, 2016, the NASDAQ Composite ended the trading session at 4,862.57, up 0.41%; the Dow Jones Industrial Average edged 0.11% higher, to finish at 17,949.37; and the S&P 500 closed at 2,102.95, up 0.19%. The gains were broad based as seven out of nine sectors ended the session in positive. Stock-Callers.com has initiated coverage on the following equities: Edwards Lifesciences Corporation (NYSE: EW), Stryker Corporation (NYSE: SYK), Accuray Inc. (NASDAQ: ARAY), and ABIOMED Inc. (NASDAQ: ABMD). Learn more about these stocks by accessing their free trade alerts at:
ABMD: 115.93 (+1.78), EW: 105.37 (+0.65), ARAY: 5.35 (+0.16), SYK: 122.65 (+0.36)

ABIOMED Has Returned 20.8% Since SmarTrend Recommendation (ABMD)
Comtex SmarTrend(R) - Tue Jun 14, 1:40PM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 3 months, ABIOMED has returned 20.79% as of today's recent price of $101.83.
ABMD: 115.93 (+1.78)

How Rewarding Investors Believe These Medical Appliances and Equipment Stocks are? - Edwards Lifesciences, Stryker, Accuray, and ABIOMED
PR Newswire - Wed Jun 08, 7:55AM CDT
Increasing demands for new developments are driving up growth in the Medical Appliances and Equipment space, one of the biggest industries in the U.S. Healthcare sector. ActiveWallSt.com has lined the following stocks for investors' assessment: Edwards Lifesciences Corp. (NYSE: EW), Stryker Corp. (NYSE: SYK), Accuray Inc. (NASDAQ: ARAY), and ABIOMED Inc. (NASDAQ: ABMD). Access these stocks complimentary alerts at:
ABMD: 115.93 (+1.78), EW: 105.37 (+0.65), ARAY: 5.35 (+0.16), SYK: 122.65 (+0.36)

Abiomed to Present at the William Blair 2016 Growth Stock Conference
GlobeNewswire - Tue Jun 07, 7:00AM CDT
Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the William Blair 2016 Growth Stock Conference on Tuesday, June 14, 2016 at 9:30 a.m. CDT. The conference will be held at the Four Seasons Hotel in Chicago, IL.
ABMD: 115.93 (+1.78)

20.9% Return Seen to Date on SmarTrend ABIOMED Call (ABMD)
Comtex SmarTrend(R) - Tue Jun 07, 12:59AM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 3 months, ABIOMED has returned 20.87% as of today's recent price of $101.89.
ABMD: 115.93 (+1.78)

Abiomed to Present at the Jefferies 2016 Healthcare Conference
GlobeNewswire - Fri Jun 03, 8:00AM CDT
Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the Jefferies 2016 Healthcare Conference on Thursday, June 9, 2016 at 9:30 a.m. EDT. The conference will be held at the Grand Hyatt New York in New York, NY.
ABMD: 115.93 (+1.78)

Masimo (MASI) Beats Q1 Earnings & Revenues; FY16 View Up
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:29AM CDT
Masimo Corp (MASI) reported earnings of 53 cents per share in the first quarter of 2016, which beat the Zacks Consensus Estimate by a dime.
ABMD: 115.93 (+1.78), IRMD: 21.84 (-0.29), MASI: 52.23 (-0.10), EW: 105.37 (+0.65)

Luminex (LMNX) Beats Q1 Earnings & Revenues, Guides Up
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:24AM CDT
Luminex Corporation (LMNX) reported first-quarter 2016 adjusted earnings of 27 cents per share, which comfortably surpassed the Zacks Consensus Estimate of 13 cents.
ABMD: 115.93 (+1.78), IRMD: 21.84 (-0.29), EW: 105.37 (+0.65), LMNX: 21.57 (-0.09)

Abiomed (ABMD) Down despite Q4 Earnings & Revenue Beat
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:20AM CDT
Shares of Abiomed Inc. (ABMD) fell for the second consecutive day on May 4, after the release of the company's fourth-quarter 2016 results and fiscal 2017 guidance.
ABMD: 115.93 (+1.78), IRMD: 21.84 (-0.29), BAX: 46.72 (+0.07), EW: 105.37 (+0.65)

Abiomed beats Street 4Q forecasts
Automated Insights - Tue May 03, 6:59AM CDT
DANVERS, Mass. (AP) _ Abiomed Inc. (ABMD) on Tuesday reported fiscal fourth-quarter profit of $11 million.
ABMD: 115.93 (+1.78)

Abiomed Announces Q4 FY 2016 Revenue of $94.0 Million, Up 39% Over Prior Year
GlobeNewswire - Tue May 03, 6:01AM CDT
Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported fourth quarter fiscal 2016 revenue of $94.0 million, an increase of 39% compared to revenue of $67.6 million for the same period of fiscal 2015. For fiscal year 2016, total revenue was $329.5 million, up 43% compared to revenue of $230.3 million in fiscal year 2015. This revenue exceeds the third quarter upgraded fiscal year guidance of $326 million.
ABMD: 115.93 (+1.78)

3 Scorching Hot Med-Tech Stocks In 2016
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 28, 7:21AM CDT
Healthcare has taken some lumps in the past six months, but medical-device makers have been immune to the slump. While the Nasdaq Biotech ETF has tumbled 13.4% since last October, the iShares Medical Device ETF has climbed by 9.3%. That's a...
BSX: 23.98 (+0.08), ABMD: 115.93 (+1.78), EW: 105.37 (+0.65), IBB: 271.43 (+0.30), IHI: 140.35 (+0.40)

ABIOMED Shares Up 21.0% Since SmarTrend's Buy Recommendation (ABMD)
Comtex SmarTrend(R) - Wed Apr 27, 1:33AM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 2 months, ABIOMED has returned 21.03% as of today's recent price of $102.03.
ABMD: 115.93 (+1.78)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Blokees Unveils 90+ New Wonders at Shanghai Fest

A Grand Stage for New Arrivals Picture this: In the bustling and glittering chaos that was the Wonder Festival Shanghai 2026, held from October 3 to 4, Blokees laid down a major marker. More than 500 products, an artillery of imagination and craftsmanship, were on deck across their key lines—Blokees Model Kits and BLOKEES WHEELS. With 90 brand-new creations making their...

Power Knot MEA Wins THE BIZZ 2026 for Excellence

Setting the Pace in Waste Management If there's one thing that sticks in my craw, it's how businesses handle food waste. Power Knot Middle East (PKME) seems to have cracked the code by not just leading the charge in organic waste management but also bagging THE BIZZ 2026 award. They’re not just playing industry games; PKME's pulling the strings with real leadership and...

Monteverde's Equity Alert: Scrutinizing Recent M&A Deals

Diving Into M&A Deals Under Monteverde's Lens Wall Street’s not just about suits and skyscrapers; it’s about the nitty-gritty of deals and whether those numbers add up in the investor's favor. So, when Monteverde & Associates PC throws its weight into scrutinizing mergers and acquisitions, you better believe it's worth a second look. See, they’re digging into four...

ARTBOX Brings Korean Lifestyle Magic to LA Pop-Up

ARTBOX: From Seoul to La-La Land Here's what caught my eye. It's 2026, and Korean lifestyle retailer ARTBOX is making a splash in the U.S.—kicking things off with a pop-up in LA. Now, usually, I'd be skeptical about pop-ups, but you've got to admire the audacity and timing here. They've picked Melrose Avenue, a hotspot for all things trendy, to introduce their mix of...

Monteverde Probes Four Key M&A Deals for Fairness

Examining the Intricacies of Pending M&A The merger and acquisition landscape can be vicious, especially when the sharks—those pesky class action lawyers—start circling. And let me tell you, Monteverde & Associates PC is diving headfirst into the fray, launching inquiries into a handful of these deals. This isn't your first stroll down Wall Street if you’ve seen one...

SiBionics and PharmaSens Unveil Diabetes Tech at EASD

Shaking Up Diabetes Care: New Tech Unveiled Imagine a world where managing diabetes isn't a juggling act with multiple devices. That's precisely the future SiBionics and PharmaSens are pitching at the European Association for the Study of Diabetes (EASD) 2026 in Milan. Now, let me tell you, these guys aren't just playing around with ideas; they're aiming to radically...

Monster Energy Dominates Skateboard Podium at SLS Paris

Monster Energy's Skateboard Triumph Hold the front page, because Monster Energy just pulled off a clean sweep in Paris. The company's team riders dominated the Men's Skateboard Street competition at the SLS Paris 2026, with the iconic Nyjah Huston snagging the top spot. It's a story filled with triumph, grit, and a dash of raw talent in a vibrant field of international...

Black Culture Icon: Plastic-Covered Couch Takes Stage

A Plastic-Laden Piece of History Makes Art Who'd have thought a plastic-covered couch would turn into a cultural artifact? This iconic staple in Black households has done just that, debuting at Brooklyn's CultureCon in a fresh guise. It's more than just an upcycled furniture piece; it's a living archive that encapsulates Black culture, joy, and resilience. The Heart...

Unpacking Monteverde's M&A Investigations Hold your horses, folks! The M&A Class Action Firm is stirring the pot with its latest inquiries into some high-profile mergers. We're looking at Lisata Therapeutics, Flag Ship Acquisition Corporation, Baldwin Insurance Group, and ACV Auctions. So what's got Juan Monteverde's legal eagles swooping in on these deals? Well, are we...

Lawsuit Highlights Inaction in School Bus Tragedy

Seeking Justice Amid Heartbreak Tragedy rarely arrives whispered on the wind—more often, it's the train wreck some saw coming long before it hits. The tragic death of Jenna Menias, a 6-year-old from Frankfort, Illinois, falls squarely in this camp. The family's legal lions, Corboy & Demetrio, have slapped two school districts—District 210 and 157-C—with a wrongful...